Exudative Age-Related Macular Degeneration: Case Report with Clinical Stabilization after Anti-VEGF Therapy

Authors

  • Lucas Couto Nunes Unic

DOI:

https://doi.org/10.36557/2674-8169.2026v8n2p989-993

Keywords:

Degeneração macular relacionada à idade; DMRI exsudativa; Anti-VEGF; Escotoma central; Oftalmologia

Abstract

Age-related macular degeneration (AMD) is one of the leading causes of visual impairment in individuals over 60 years old, particularly in its exudative form, characterized by choroidal neovascularization. Early diagnosis and appropriate treatment are essential for preserving visual function. This article aims to report a case of exudative AMD in a 64-year-old patient who presented with central scotoma in the left eye and achieved clinical stabilization after intravitreal anti-VEGF therapy. This case highlights the importance of early symptom recognition, proper diagnostic investigation, and specialized follow-up for improved visual prognosis.

Downloads

Download data is not yet available.

References

Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040. Lancet Glob Health.

Ferris FL, Wilkinson CP, Bird A, et al. Clinical classification of age-related macular degeneration. Ophthalmology.

Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med.

Schmidt-Erfurth U, Chong V, Loewenstein A, et al. Guidelines for the management of neovascular age-related macular degeneration. Ophthalmology.

Published

2026-02-19

How to Cite

Couto Nunes, L. (2026). Exudative Age-Related Macular Degeneration: Case Report with Clinical Stabilization after Anti-VEGF Therapy. Brazilian Journal of Implantology and Health Sciences, 8(2), 989–993. https://doi.org/10.36557/2674-8169.2026v8n2p989-993